This compound consistently enhances neurogenesis and improves cognitive functions in AD animal models through Wnt/β-catenin signaling via the direct phosphorylation of GSK-3β at Ser9 (inhibitory site), thereby stabilizing β-catenin to induce NeuroD1-mediated neuronal differentiation [100,101]. The gene discussed is GSK3B; the disease is Alzheimer disease.